LK Shields acted for the shareholders of Nualtra Limited, on its sale to Ajinomoto Cambrooke, Inc., part of the Ajinomoto group.
Founded in 2012, Nualtra develops and provides medical foods to public health systems for the treatment of patients with disease-related malnutrition. Nualtra has been the fastest-growing oral nutrition supplement provider in the UK and Ireland for several years. Nualtra owns the ingredients and formulas used in its products which are manufactured in several European locations and distributed via pharmaceutical wholesalers.
Ajinomoto Co. Inc is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. The Ajinomoto Group has offices in 35 countries and regions and sells products in more than 30 countries. In fiscal 2019, sales were USD 10.1 billion.
Nualtra’s Chief Executive Officer, Mark Lane said of the acquisition:
“We received several strong offers for our business but Cambrooke was the obvious choice for everyone involved.”
The LK Shields team comprised Gerry Halpenny (Partner, Corporate), Jennifer McGuire (Partner, Corporate), James Byrne (Associate, Corporate), Stephen Gamble (Associate, Corporate), Jane O’Grady (Associate, Data Privacy and Technology), and Jennifer O’Neill (Consultant, Employment).
We regularly publish useful content on a wide range of legal and business topics. Please click the button below if you would like to receive these by email.Subscribe